CSN6‐SPOP‐HMGCS1 Axis Promotes Hepatocellular Carcinoma Progression via YAP1 Activation
Advanced Science · 2024-04 · 11 (14)
DOI: 10.1002/advs.202306827 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 02.02.2024. Verfasst von Kai Li und 24 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Disease, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510655,…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Hydroxymethylglutaryl-CoA Synthase, Liver Neoplasms, Repressor Proteins. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program, National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.
Abstract (Originalsprache)
Cholesterol metabolism has important roles in maintaining membrane integrity and countering the development of diseases such as obesity and cancers. Cancer cells sustain cholesterol biogenesis for their proliferation and microenvironment reprograming even when sterols are abundant. However, efficacy of targeting cholesterol metabolism for cancer treatment is always compromised. Here it is shown that CSN6 is elevated in HCC and is a positive regulator of hydroxymethylglutaryl‐CoA synthase 1 (HMGCS1) of mevalonate (MVA) pathway to promote tumorigenesis. Mechanistically, CSN6 antagonizes speckle‐type POZ protein (SPOP) ubiquitin ligase to stabilize HMGCS1, which in turn activates YAP1 to promote tumor growth. In orthotopic liver cancer models, targeting CSN6 and HMGCS1 hinders tumor growth in both normal and high fat diet. Significantly, HMGCS1 depletion improves YAP inhibitor efficacy in patient derived xenograft models. The results identify a CSN6‐HMGCS1‐YAP1 axis mediating tumor outgrowth in HCC and propose a therapeutic strategy of targeting non‐alcoholic fatty liver diseases‐ associated HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Disease, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510655, China.
- Guangdong Research Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510655, China.
- Key Laboratory of Human Microbiome and Chronic Diseases (Sun Yat-sen University), Ministry of Education, Guangzhou, 510655, China.
- Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510655, China.
- Department of Experiment & Research, South China Hospital, Shenzhen University, Shenzhen, 518116, China.
- Department of Hepatobiliary, Pancreatic and Splenic surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510655, China.
ORCID-Profile: Kai Li, Mong-Hong Lee
Förderung
- National Key Research and Development Program
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- "President Specific Funding" of The Sixth Affiliated Hospital, Sun Yat-sen University
- Guangdong Provincial Clinical Research Center for Digestive Diseases
- National Key Clinical Discipline
- National Key Research and Development Program of China
Zitieren
APA
Li, K., Zhang, J., Lyu, H., Yang, J., Wei, W., Wang, Y., Luo, H., Zhang, Y., Jiang, X., Yi, H., Wang, M., Zhang, C., Wu, K., Xiao, L., Wen, W., Xu, H., Li, G., Wan, Y., Yang, F., …, & Lee, M. H. (2024). CSN6‐SPOP‐HMGCS1 Axis Promotes Hepatocellular Carcinoma Progression via YAP1 Activation. Advanced Science, 11(14). https://doi.org/10.1002/advs.202306827
Vancouver
Li K, Zhang J, Lyu H, Yang J, Wei W, Wang Y, et al. CSN6‐SPOP‐HMGCS1 Axis Promotes Hepatocellular Carcinoma Progression via YAP1 Activation. Advanced Science. 2024;11(14). doi:10.1002/advs.202306827
BibTeX
@article{Li2024,
author = {Li, Kai and Zhang, Jiayu and Lyu, Haiwen and Yang, Jinneng and Wei, Wenxia and Wang, Yuzhi and Luo, Haidan and Zhang, Yijing and Jiang, Xin and Yi, Hairong and Wang, Mengan and Zhang, Caiyun and Wu, Kang and Xiao, Lishi and Wen, Weijie and Xu, Hui and Li, Guolin and Wan, Yunle and Yang, Fang and Yang, Runxiang and Fu, Xinhui and Qin, Baifu and Zhou, Zhongguo and Zhang, Haipeng and Lee, Mong-Hong},
title = {CSN6‐SPOP‐HMGCS1 Axis Promotes Hepatocellular Carcinoma Progression via YAP1 Activation},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {14},
doi = {10.1002/advs.202306827}
}
EUVIMED